跳至主要内容
临床试验/CTRI/2025/08/093931
CTRI/2025/08/093931尚未招募2/3 期

A Randomized Open-Labelled Clinical Study To Evaluate The Role Of Sansran Karma In Vicharchika W.S.R. To Eczema In Children

MS Regional Ayurveda Research Institute Jaipur1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2025年9月10日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
80
试验地点
1
主要终点
Change in the EASI (ECZEMA AREA AND SEVERITY INDEX) score.

研究概览

简要总结

Vicharchika (Eczema) is a common skin disorder, particularly in children, characterized by Pidika, Kandu, Srava, Vaivarnyata, Ruja, Daha, and Rukshata. Sansran Karma will be done first, and then external application of Karveeradhya Taila and internal administration of Haridradi Vati in group A. Sansran Karma, an Ayurvedic treatment procedure, is traditionally believed to have beneficial effects on skin conditions like Vicharchika. In group B external application of Karveeradhya Taila  and internal administration of Haridradi Vati will be given. This clinical trial aims to assess the effectiveness of Sansran Karma in treating Eczema in children.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
8.00 Year(s) 至 16.00 Year(s)(—)
性别
All

入选标准

  • 1.Patient with classical signs and symptoms of Vicharchika (Eczema) of either sex.
  • 2.Children between the age group of 08 to 16 years.
  • 3.Patient-Oriented Eczema Measure (Poem) score between 08 to 24.

排除标准

  • 1.Patients below the age of 08 years and more than 16 years will be excluded.
  • 2.The patient suffers from any another chronic skin disease and immune suppressed systemic disorders.
  • 3.Vicharchika (Eczema) with secondary infections.
  • 4.Patient suffering from any other systemic disorders like tuberculosis, Diabetes, HIV, leprosy, etc.
  • 5.Eczemaleads to complications such as eczematization, secondary streptococcal infection, urticaria, etc.
  • 6.Patient-Oriented Eczema Measure (Poem) score less than 08 and more than
  • 7.Virechana Karma Ayogya (Contraindication of purgation therapy) condition.

结局指标

主要结局

Change in the EASI (ECZEMA AREA AND SEVERITY INDEX) score.

时间窗: Base line, 15th day, 30th day, 45th day, 60th day, 90th day

次要结局

  • 1.Change in classical signs and symptoms of Vicharchika.(2.Changes in Hematological parameters for the safety of drugs.)

研究者

发起方
MS Regional Ayurveda Research Institute Jaipur
申办方类型
Research institution
责任方
Principal Investigator
主要研究者

Dr. Kailash Chandra Kataria

Government Ayurveda College, Bikaner

研究点 (1)

Loading locations...

相似试验